Seer: Pay

Seer paid its 3 named executives $5.8M in total in FY2024 (Dec). CEO Omid Farokhzad, M.D. was paid $3.5M of that.

Pay$100 in the stock at the end of FY21 → $10
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Omid Farokhzad, M.D.Chief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years
David HornPresident and Chief Financial Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years
Elona KoganFormer Chief Legal Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 11 peers with pay on file was $5.5M. The CEO of Seer was paid $3.5M, 35% below the median.

  1. 1Standard Biotools
  2. 2Twist Bioscience
  3. 3Castle Biosciences
  4. 4Veracyte
  5. 5Quanterix
  6. 6Butterfly Network
  7. 7Adaptive Biotechnologies
  8. 8Quantum-Si
  9. 9Seer
  10. 10Codexis
  11. 11Kodiak Sciences
  12. 12Personalis
  13. 13Akoya Biosciences, Inc.Not disclosed
  14. 14AlectorNot disclosed
  15. 15Bionano Genomics, Inc.Not disclosed
  16. 16NanoString TechnologiesNot disclosed
  17. 17RAPT Therapeutics, Inc.Not disclosed
  18. 18Rapid Micro BiosystemsNot disclosed
  19. 19SI-BONE, Inc.Not disclosed
  20. 20Silk Road Medical IncNot disclosed
  21. 21SomaLogic, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.